Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Abnormal Liver Function Test Interpretation

Recurrent Nasal Polyps Management – When to Refer

Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow

Practical Strategies to Address Falling Vaccination Rates in Mums and Bubs

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne